The ISEQ index of Irish shares remained largely unchanged today, closing down 0.01% at 3306.

The ISEQ index of Irish shares finished up 13 points to 3,280, a gain of 0.4%.

Improving prospects of Greece getting its second bailout, thus keeping the euro zone intact for the time being, boosted international stock markets yesterday.

The ISEQ index of Irish shares finished up 31 points to 3,207, a gain of 1%.

The ISEQ index of Irish shares closed down five points to 3,093, a drop of 0.16%.

The ISEQ index of Irish shares closed down three points to 3,065, a drop of 0.1%.

DISAGREEMENT between Germany and France over the use of the European Central Bank (ECB) as a rescue lender to shore up the eurozone debt crisis; and a continuing rise in borrowing costs, sent international markets back into decline, yesterday.

INTERNATIONAL stockmarkets advanced for a second day’s growth, yesterday, on the back of the European Central Bank’s unexpected interest rate cut and news that a referendum on the latest Greek bailout is now unlikely in its intended form.

THE ISEQ index of Irish shares fell over 4% yesterday, a pattern consistent across all major international stock exchanges in light of Greece’s decision to hold a referendum on its latest bailout offer.

MERRION Pharmaceuticals is shedding 20 jobs at its headquarters in Citywest, Dublin, to reduce annual cash expenditures by 32%, following losses of €2.04m for the first half of the year.

The ISEQ index closed down 7.55 points to 2,926.45, a drop of 0.26%.

The ISEQ index of Irish shares closed up 15.77 points to 2,925.03, a gain of 0.54% .

IRISH drug development company Merrion Pharmaceuticals has announced a new collaboration agreement with Danish healthcare firm, Novo Nordisk, that will evaluate the capabilities of Merrion’s GIPET technology to improve the delivery of an unnamed compound.

The ISEQ index of Irish shares closed up 54.42 points to 2,775.74, a rise of 2.00%.

The ISEQ index of Irish shares closed down 2.86 points to 2,683.40, a drop of 0.11%.

The ISEQ index of Irish shares was up 36.28 points to 2,746.95 by midday today, a rise of 1.34%.

CREDITORS of an insolvent taxi firm owned by rogue financier Breifne O’Brien have been told that they are unlikely to receive any money owed to them.

MERRION Pharmaceuticals, the Irish drug development company, is actively looking at pursuing more collaboration relationships with other pharmaceutical companies, in the light of producing a promising set of first-half financial results.

The ISEQ index of Irish shares closed down 52.21 points to 2,802.62, a fall of 1.83%.

The ISEQ index of Irish shares closed up 44.39 points to 2,857.96 today, a rise of 1.58%.

The ISEQ index of Irish shares closed down 24.72 points to 2,959.25, a drop of 0.83%.

MEDICAL test kit provider Trinity Biotech has reported pre-tax profits of $54.2 million (€41.5m) for the first half of the year, up from $6.2m for the same period last year.

The ISEQ index of Irish shares closed up 64.48 points to 2,937.59 today, a rise of 2.24%.

The ISEQ index of Irish shares recovered in some measure from yesterday's losses, closing up 102.65 points or 3.70% at 2,879.20.

Dublin: Drugs development firm, Merrion Pharmaceuticals, has been granted a further patent in the US protecting its key Orazol product.

MERRION Pharmaceuticals has slashed its annual losses and boosted its revenues by €5 million.

The ISEQ index of Irish shares rose 41.47 points or 1.42% in today's trading, finishing at 2,965.29.

STRONG gains for the banks and other key Irish stocks dragged the ISEQ back up towards the 3,000 point mark as it reclaimed nearly 4% after a poor showing in the past week.

The ISEQ index of Irish shares recovered some ground today, closing up 2.73% after yesterday's sell-off saw a slump of more than 6.5%.

The ISEQ index of Irish shares edged into the black today, closing up 2.21 points at 3,233.03.

ISEQ-quoted Merrion Pharmaceuticals today reported a net loss of €2.3m for the six months to end June, compared to a loss of €2.1m for H1 2008.

The ISEQ index of Irish shares fell 45.52 points today, closing at 2,835.55.

ALTHOUGH the ISEQ bowed out for the week with a near 1% dip yesterday, throughout July the Irish market has maintained the strong recovery item barked on in the second quarter of the year, after hitting a 12-month low in early March.

MERRION Pharmaceuticals, the Dublin-based drug-maker, has benefited from falling values in the commercial property market by expanding its manufacturing facilities here in a bid to accelerate the development of its product pipeline.

The ISEQ index of Irish shares was marginally up in early trading this morning, gaining 8 points to 2,454.44 by 11.50am.

The ISEQ index of Irish shares suffered some small losses in this morning's early trading.

The ISEQ index of Irish shares closed at 2,129.35 this evening, a fall of 37.46 points or 1.73%.

DUBLIN-based drug-making firm, Merrion Pharmaceuticals has reported a solid set of results for 2008; showing a marked reduction in net losses and a 186% surge in revenue to €1.34 million.

The ISEQ index of Irish shares was valued at 2,397.65 at 11am this morning, an increase of 38.12 or 1.62%.

The ISEQ index closed down 48.29 points at 2,359.53, as investors weighed up the details of the recapitalisation of AIB and Bank of Ireland. The terms of the deal include e3.5bn in capital being injected into each bank in the form of preference shares.

The ISEQ index of Irish shares was valued at 2,377.11 at 11am this morning, a fall of 30.71 points or 1.28%.

Merrion Pharmaceuticals has appointed of Dr John Fox as chief development officer.

MERRION Pharmaceuticals said on Friday it had called off plans for an initial public offering on the Nasdaq due to tough current market conditions.